These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 23291248)

  • 21. Free radicals in Parkinson's disease.
    Koutsilieri E; Scheller C; Grünblatt E; Nara K; Li J; Riederer P
    J Neurol; 2002 Sep; 249 Suppl 2():II1-5. PubMed ID: 12375056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heredity in Parkinson's disease: new findings.
    Lev N; Melamed E
    Isr Med Assoc J; 2001 Jun; 3(6):435-8. PubMed ID: 11433638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention.
    Tansey MG; McCoy MK; Frank-Cannon TC
    Exp Neurol; 2007 Nov; 208(1):1-25. PubMed ID: 17720159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene and protein signatures in sporadic Parkinson's disease and a novel genetic model of PD.
    Mandel SA; Fishman T; Youdim MB
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S242-7. PubMed ID: 18267243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modeling neuroinflammatory pathogenesis of Parkinson's disease.
    Barnum CJ; Tansey MG
    Prog Brain Res; 2010; 184():113-32. PubMed ID: 20887872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alpha-synuclein and Parkinson's disease: a proteomic view.
    Fasano M; Lopiano L
    Expert Rev Proteomics; 2008 Apr; 5(2):239-48. PubMed ID: 18466054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxidative stress and genetics in the pathogenesis of Parkinson's disease.
    Zhang Y; Dawson VL; Dawson TM
    Neurobiol Dis; 2000 Aug; 7(4):240-50. PubMed ID: 10964596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A systematic review of molecular approaches that link mitochondrial dysfunction and neuroinflammation in Parkinson's disease.
    Mani S; Sevanan M; Krishnamoorthy A; Sekar S
    Neurol Sci; 2021 Nov; 42(11):4459-4469. PubMed ID: 34480241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular pathogenesis of Parkinson's disease.
    Gandhi S; Wood NW
    Hum Mol Genet; 2005 Sep; 14(18):2749-55. PubMed ID: 16126732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease.
    Anglade P; Vyas S; Javoy-Agid F; Herrero MT; Michel PP; Marquez J; Mouatt-Prigent A; Ruberg M; Hirsch EC; Agid Y
    Histol Histopathol; 1997 Jan; 12(1):25-31. PubMed ID: 9046040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel cell death signaling pathways in neurotoxicity models of dopaminergic degeneration: relevance to oxidative stress and neuroinflammation in Parkinson's disease.
    Kanthasamy A; Jin H; Mehrotra S; Mishra R; Kanthasamy A; Rana A
    Neurotoxicology; 2010 Sep; 31(5):555-61. PubMed ID: 20005250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endoplasmic reticulum and mitochondria interplay mediates apoptotic cell death: relevance to Parkinson's disease.
    Arduíno DM; Esteves AR; Cardoso SM; Oliveira CR
    Neurochem Int; 2009 Sep; 55(5):341-8. PubMed ID: 19375464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of inflammatory and oxidative stress mechanisms in the pathogenesis of Parkinson's disease: focus on astrocytes.
    Niranjan R
    Mol Neurobiol; 2014 Feb; 49(1):28-38. PubMed ID: 23783559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxidative stress and neuroinflammation in the story of Parkinson's disease: Could targeting these pathways write a good ending?
    Hassanzadeh K; Rahimmi A
    J Cell Physiol; 2018 Jan; 234(1):23-32. PubMed ID: 30078201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammasomes: An Emerging Mechanism Translating Environmental Toxicant Exposure Into Neuroinflammation in Parkinson's Disease.
    Anderson FL; Coffey MM; Berwin BL; Havrda MC
    Toxicol Sci; 2018 Nov; 166(1):3-15. PubMed ID: 30203060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circadian rhythms, Neuroinflammation and Oxidative Stress in the Story of Parkinson's Disease.
    Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
    Cells; 2020 Jan; 9(2):. PubMed ID: 32012898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroinflammation in Parkinson's disease: is there sufficient evidence for mechanism-based interventional therapy?
    Tansey MG; Frank-Cannon TC; McCoy MK; Lee JK; Martinez TN; McAlpine FE; Ruhn KA; Tran TA
    Front Biosci; 2008 Jan; 13():709-17. PubMed ID: 17981581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Possible role of Epoxyeicosatrienoic acid in prevention of oxidative stress mediated neuroinflammation in Parkinson disorders.
    Lakkappa N; Krishnamurthy PT; Hammock BD; Velmurugan D; Bharath MM
    Med Hypotheses; 2016 Aug; 93():161-5. PubMed ID: 27372879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Update on the Role of Nitric Oxide in the Neurodegenerative Processes of Parkinson's Disease.
    Jiménez-Jiménez FJ; Alonso-Navarro H; Herrero MT; García-Martín E; Agúndez JA
    Curr Med Chem; 2016; 23(24):2666-2679. PubMed ID: 27776473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidative stress in Parkinson's disease.
    Schapira AH
    Neuropathol Appl Neurobiol; 1995 Feb; 21(1):3-9. PubMed ID: 7770118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.